Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000701426) titled 'Feasibility Study of a Combined Glucose and Ketone Sensor in People with and without Diabetes' on July 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Primary Sponsor: St Vincent's Hospital Melbourne
Condition:
type 1 diabetes
type 1 diabetes
Metabolic and Endocrine - Diabetes
Intervention:
Participants enrolled at St Vincent's Hospital Melbourne will continuously wear a combined glucose and ketone monitor (CGKM) over 72 hours under free-living conditions. Standardized meal and ketone drink tests in the clinical trial centre including frequent blood sampl...